Marian M Mikhail, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12916 Central Ave, Chino, CA 91710 Phone: 909-342-9181 Fax: 909-342-9172 |
Dr. Noah Chung, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3943 Grand Ave, Chino, CA 91710 Phone: 909-590-7597 |
Vaishali Shah, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12059 Central Ave, Chino, CA 91710 Phone: 909-627-4012 |
Nicki Fotiadis, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12835 Mountain Ave, Chino, CA 91710 Phone: 909-548-6366 |
Alan Bui Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3943 Grand Ave, Chino, CA 91710 Phone: 909-590-7597 Fax: 909-590-9692 |
Dr. Cameron James Kerr, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13622 Van Horn Cir W, Chino, CA 91710 Phone: 909-525-0004 |
News Archive
This November, in recognition of National Family Caregivers Month, Home Instead Senior Care® has some helpful advice for the 43 million Americans currently caring for family members.* The leading global provider of home care services for seniors polled its top professional CAREGivers(SM) – recipients of its annual CAREGiver of the Year award – for their best caregiving tips.
Midostaurin added to standard chemotherapy is the first targeted treatment to improve survival of a high-risk, genetically defined subgroup of patients with acute myeloid leukemia (AML), reported Dr. Richard Stone, of Dana-Farber Cancer Institute, on behalf of the Alliance for Clinical Trials in Oncology group, in a plenary session at the 57th American Society of Hematology Annual Meeting and Exposition in Orlando.
iCAD, Inc. ("iCAD"), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy solutions for the early identification and treatment of cancer, today announced it has priced a registered firm commitment underwritten public offering of 2,400,000 shares of its common stock at a price to public of $11.00 per share.
Cancer cells need food to survive and grow. They're very good at getting it, too, even when nutrients are scarce. Many scientists have tried killing cancer cells by taking away their favorite food, a sugar called glucose. Unfortunately, this treatment approach not only fails to work, it backfires-glucose-starved tumors actually get more aggressive.
The governing board of the California Institute for Regenerative Medicine unanimously approved this week two grants worth more than $2.2 million to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.
› Verified 8 days ago